HRT Financial’s Astria Therapeutics ATXS Stock Holding History

HRT Financial’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-102,453	Closed	-$1.34M	–	3761
2025 Q4	$1.34M	Buy	+102,453	New	+$1.22M	﹤0.01%	1548
2025 Q3	–	Sell	-22,366	Closed	-$119K	–	2842
2025 Q2	$119K	Buy	+22,366	New	+$108K	﹤0.01%	2175
2021 Q3	–	Sell	-2,811	Closed	-$35K	–	3261
2021 Q2	$35K	Buy	+2,811	New	+$36.5K	﹤0.01%	2700
2018 Q3	–	Sell	-400	Closed	-$23K	–	405
2018 Q2	$23K	Buy	+400	New	+$36.9K	0.01%	258

HRT Financial's ATXS Position: Q1 2026 in Review

HRT Financial sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 102,453 shares — an estimated $1.34M sold.

HRT Financial first reported a position in ATXS in Q2 2018 and held it in 4 quarters. The position peaked at $1.34M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

HRT Financial reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
HRT Financial sold 102,453 Astria Therapeutics shares in Q1 2026, an estimated $1.34M.
HRT Financial first reported a position in Astria Therapeutics in Q2 2018 and held it in 4 quarters.
HRT Financial's Astria Therapeutics position peaked at $1.34M in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.